Chensu Wang
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Immunotherapy and Immune Responses 5
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 3
-
- Lipid Membrane Structure and Behavior 3
- Co-authors
- Jinming Gao (9 shared papers)Gang Huang (8 shared papers)Yang Li (7 shared papers)Zhaohui Wang (4 shared papers)Tian Zhao (5 shared papers)Baran D. Sumer (4 shared papers)Min Luo (2 shared papers)Jingyuan Li (2 shared papers)
- Journals
- Cell Reports (3 papers)Nature Communications (3 papers)Cancer Immunology Research (2 papers)Nature Nanotechnology (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Chensu Wang
27 papers receiving 2.5k citations
Chensu Wang's Hit Papers
Peers
Comparison fields: 5 of 104
- Immunology 926
- Biomaterials 428
- Biomedical Engineering 1.0k
- Oncology 501
- Molecular Biology 949
Countries citing papers authored by Chensu Wang
This map shows the geographic impact of Chensu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chensu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chensu Wang more than expected).
Fields of papers citing papers by Chensu Wang
This network shows the impact of papers produced by Chensu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chensu Wang. The network helps show where Chensu Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chensu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A STING-activating nanovaccine for cancer immunotherapy Hit paper breakdown → | 2017 | 776 |
| 2 | Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor Hit paper breakdown → | 2019 | 339 |
| 3 | 2011 | 273 | |
| 4 | 2017 | 203 | |
| 5 | 2016 | 175 | |
| 6 | 2017 | 122 | |
| 7 | 2016 | 112 | |
| 8 | 2016 | 82 | |
| 9 | 2015 | 76 | |
| 10 | 2021 | 67 | |
| 11 | 2018 | 65 | |
| 12 | 2019 | 57 | |
| 13 | 2015 | 38 | |
| 14 | 2021 | 31 | |
| 15 | 2011 | 25 | |
| 16 | 2021 | 21 | |
| 17 | 2016 | 16 | |
| 18 | 2021 | 10 | |
| 19 | 2023 | 8 | |
| 20 | 2019 | 5 |
About Chensu Wang
Chensu Wang is a scholar working on Immunology, Molecular Biology, Biomedical Engineering, Oncology and Biomaterials, having authored 27 papers that have together received 2.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (4 papers), CAR-T cell therapy research (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (3 papers), Graphene and Nanomaterials Applications (3 papers) and Lipid Membrane Structure and Behavior (3 papers). The work is most often cited by research in Immunology (926 citations), Biomaterials (428 citations), Biomedical Engineering (1.0k citations), Oncology (501 citations) and Molecular Biology (949 citations). Chensu Wang has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Jinming Gao, Gang Huang, Yang Li, Zhaohui Wang, Tian Zhao, Baran D. Sumer, Min Luo, Jingyuan Li, Christian Amatore and Yu Chen. Their work appears in journals such as Cell Reports, Nature Communications, Cancer Immunology Research, Nature Nanotechnology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.